Angiography Devices Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2032 | Says FMI Analyst

 The Global Angiography Devices Market is anticipated to be worth US$ 12,116.7 million in 2022. The rising spectrum of application and technological innovation is expected to be the key development drivers for the market. Overall angiography device revenue is expected to expand at a 6.2% CAGR between 2022 and 2032, reaching roughly US$ 22,112 million by the end of 2032.

Angiography Devices
Angiography Devices

Angiography is an imaging procedure that provides visualization of the blood vessel to detect narrow, blocked, enlarged arteries or veins in the body. Local or general anesthesia has been given to the patient during the angiography procedure. This procedure uses various imaging technologies such as Magnetic Resonance Imaging, Computed Tomography, X-ray, and others. The superior quality of angiography imaging over conventional techniques is increasing the adoption of angiography devices, especially for heart-related disorders.

The MRI and CT angiography devices would be the most prominent products in this market owing to its efficacy, minimal side effects, and short duration in terms of outcome. Commercialization of high end imaging technologies and increasing affordability of patients has increased the scope of hybrid angiography devices, in the developed regions. The demand for angiography devices in developing regions would get reduced owing to its relatively saturated market situation. This market would be further driven by the replacement of old devices

Angiography devises Market: Overview

By device, the angiography device market was dominated by more advanced technologies such as MRI and CT, owing to their high efficiency over conventional technologies. Recently launched, Real-time 3D echocardiography by Siemens Healthcare is one of the key development in angiography devices market, which is used to diagnose various heart and coronary conditions. By procedure, coronary angiography and pulmonary angiography are the dominating procedure, owing to its high prevalence. By end-users, hospitals and surgical centers hold promising share, followed by diagnostic centers. This is due to premium pricing of angiography devices, which is unaffordable for the medium scale diagnostic centers. By disease indication, Coronary Artery Disease (CAD) is the leading segment due to its high incidence and absence of alternative diagnostic technique.

Angiography Devices Market: Drivers and Restraints

Increasing CVD incidences, growing number of geriatric population, dysfunctional lifestyle, growing demand for sophistication diagnostic procedures are driving the growth of angiography devices market, globally. Also, the rising awareness for cardiovascular disease diagnosis and treatment, favorable government regulation to commercialize angiography devices are the additional factors fueling the growth of angiography devices market. However, the high cost angiography devices, lack of reimbursement, and unaffordability across emerging economies are some of the factors impeding the market growth. However, the companies operating in this market are actively focusing on the commercialization of low cost system to grab the highest market share in emerging economies.

Access Full Report: https://www.futuremarketinsights.com/reports/angiography-devices-market

Angiography Devices Market: Key Players

Leading players operating in angiography devices includes, Shimadzu Corporation, Royal Philips Electronics, Siemens Healthcare, GE Healthcare, Toshiba Medical System Corporation, Shimadzu Corporation, St. Jude Medical, Inc., Toshiba Medical Systems Corporation, Cordis Corporation, Medtronic, Inc., and Abbott Vascular (Abbott Laboratories). Companies operating in this market are seeking novel products to gain core competencies in the market. These companies are also conducting collaborative studies with clinical research institutes to sustain their market position.

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more